STIEFEL LABORATORIES (U.K.) LTD

Active London

Non-trading company

0 employees website.com
Non-trading company
S

STIEFEL LABORATORIES (U.K.) LTD

Non-trading company

Founded 15 Dec 1964 Active London, United Kingdom 0 employees website.com
Non-trading company
Accounts Submitted 19 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 29 Sept 2025 Next due 13 Oct 2026 5 months remaining
Net assets £19M £702K 2024 year on year
Total assets £19M £938K 2024 year on year
Total Liabilities £483K £236K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for STIEFEL LABORATORIES (U.K.) LTD (00831160), an active company based in London, United Kingdom. Incorporated 15 Dec 1964. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£18.85M

Increased by £702.00k (+4%)

Total Liabilities

£483.00k

Increased by £236.00k (+96%)

Turnover

N/A

Employees

N/A

Debt Ratio

2%

Increased by 1 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Glaxo Group LimitedCorporate-directorUnited KingdomUnknown23 Jul 2009Active

Shareholders

Shareholders (2)

Stiefel Laboratories Legacy (ireland) Limited
62.8%
Stiefel Laboratories, Inc.
37.2%

Persons with Significant Control

Persons with Significant Control (2)

2 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,ownership Of Shares 25 To 50 Percent As Firm,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors

Setfirst Limited

United Kingdom

Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

GSK PLC united kingdom
SETFIRST LIMITED united kingdom
STIEFEL LABORATORIES (U.K.) LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Sept 2025Confirmation StatementConfirmation statement made on 2025-09-29 with no updates
19 Jun 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
19 Jun 2025AccountsAnnual accounts made up to 2024-12-31
29 May 2025AccountsAnnual accounts filed
29 May 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
29 Sept 2025 Confirmation Statement

Confirmation statement made on 2025-09-29 with no updates

19 Jun 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

19 Jun 2025 Accounts

Annual accounts made up to 2024-12-31

29 May 2025 Accounts

Annual accounts filed

29 May 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

Recent Activity

Latest Activity

Confirmation statement made on 2025-09-29 with no updates

6 months ago on 29 Sept 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

10 months ago on 19 Jun 2025

Annual accounts made up to 2024-12-31

10 months ago on 19 Jun 2025

Annual accounts filed

10 months ago on 29 May 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

10 months ago on 29 May 2025